According to Wang et al., CHB patients who were HBeAg-positive with normal ALT levels exhibited a link between reduced HBV DNA levels and more severe liver fibrosis, potentially driven by HBV mutations and immune activation (Wang et al., 2024). This evidence concerns the gene GPT and Hepatic fibrosis.